EVALUATION OF THE EFFECTIVENESS OF BOTULINUM TOXIN TYPE A IN THE COMPLEX APPROACH TO TREATMENT IN PATIENTS WITH CERVICAL DYSTONIA

被引:0
|
作者
Gusev, V. V. [1 ,2 ]
Lvova, O. A. [2 ,3 ]
Guzhina, E. Yu [4 ]
机构
[1] City Clin Hosp 23, Ekaterinburg, Russia
[2] Ural Fed Univ, Ekaterinburg, Russia
[3] Ural State Med Univ, Ekaterinburg, Russia
[4] Ctr Contemporary Technol, Ekaterinburg, Russia
关键词
Botulinum toxin type A; Complex approach; Rehabilitation; Torticollis spastica;
D O I
10.1016/j.toxicon.2018.11.107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
97
引用
收藏
页码:S43 / S44
页数:2
相关论文
共 50 条
  • [31] A CASE OF OROMANDIBULAR DYSTONIA TREATED BY BOTULINUM TOXIN TYPE A AND DRY NEEDLING
    Diracoglu, Demirhan
    Teksoz, Bahar
    Karan, Ayse
    Aksoy, Cihan
    NOBEL MEDICUS, 2009, 5 (01): : 35 - 39
  • [32] Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections
    Häkkinen, A
    Ylinen, J
    Rinta-Keturi, M
    Talvitie, U
    Kautiainen, H
    Rissanen, A
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (10): : 1684 - 1688
  • [33] Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and DystOnia: A Systematic Review
    Grigoriu, Anca-Irina
    Dinomais, Mickael
    Remy-Neris, Olivier
    Brochard, Sylvain
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2015, 96 (11): : 2067 - +
  • [34] Botulinum Toxin Type A for the Treatment of Equinus Deformity in Patients With Mucopolysaccharidosis Type II
    Nava, Esmeralda
    Weber, Peter
    Gautschi, Matthias
    Nuoffer, Jean-Marc
    Grunt, Sebastian
    JOURNAL OF CHILD NEUROLOGY, 2012, 27 (12) : 1611 - 1615
  • [35] Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients
    Gil, Ramon A.
    Hwynn, Nelson
    Fabian, Thomas
    Joseph, Sovi
    Fernandez, Hubert H.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 285 - 287
  • [36] Treatment of the spastic drop foot with botulinum toxin type A in adult patients
    Voller, B
    Földy, D
    Hefter, H
    Auff, E
    Schnider, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 : 25 - 29
  • [37] Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity
    Ward, A
    Roberts, G
    Warner, J
    Gillard, S
    JOURNAL OF REHABILITATION MEDICINE, 2005, 37 (04) : 252 - 257
  • [38] Cost of peripheral facial palsy treatment with Botulinum Toxin type A
    Herrero, D. Hernandez
    Garcia, E. Abdel Muti
    Araujo, J. Lopez
    Barrera, E. Alfonso
    Perez, S. Moraleda
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (01) : 271 - 277
  • [39] Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
    Comella, Cynthia
    Ferreira, Joaquim J.
    Pain, Emilie
    Azoulai, Marion
    Om, Savary
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 903 - 912
  • [40] CLINICAL OBSERVATION OF BOTULINUM TOXIN TYPE A ON FOOT DYSTONIA IN PARKINSON'S DISEASE
    Liu, Jing
    Zhang, Qi-Lin
    Li, Xiang
    Mao, Cheng-Jie
    Luo, Wei-Feng
    TOXICON, 2018, 156 : S69 - S69